An Open Label study to assess the safety of APL-2 as an Add-on to standard of care in subjects with PNH
Clinical Trial Grant
Awarded By
Apellis Pharmaceuticals, Inc
Start Date
December 1, 2014
End Date
November 30, 2019
Awarded By
Apellis Pharmaceuticals, Inc
Start Date
December 1, 2014
End Date
November 30, 2019